Cornea Transplant in India and UAE | Complete Patient Guide

Q: What is the cost of cornea transplant in India compared to the UAE?

For a primary, single-eye cornea transplant (DMEK or DSAEK), patients can expect to pay approximately USD 1,500–4,000 at leading NABH- and JCI-accredited hospitals in India (Chennai, Hyderabad, Mumbai, Bengaluru) and USD 4,000–9,000 at JCI- and DHA-licensed eye centres in Dubai and Abu Dhabi. These estimates include surgeon fees, theatre charges, donor cornea procurement and processing, one night of hospitalisation, and standard postoperative medications. India represents a saving of roughly 50–60% compared to the UAE for equivalent clinical quality — both destinations deploy DMEK, DALK, and femtosecond laser-assisted techniques by fellowship-trained corneal specialists. High-risk cases (repeat grafts, combined triple procedures, bilateral surgery) attract higher fees in both destinations. GAF Healthcare provides a personalised, itemised cost estimate within 48 hours of receiving your ophthalmic records and surgeon assessment.

Q: How long do I need to stay in the country before I am fit to fly home after a cornea transplant?

The minimum in-country stay before international flight clearance is typically 3 weeks for uncomplicated DMEK or DALK, and up to 4–6 weeks for penetrating keratoplasty (PK) or complex cases. The key clinical milestones that must be met before flying are: (1) a fully formed, pressure-stable anterior chamber; (2) complete graft adherence confirmed on slit-lamp and/or anterior-segment OCT; (3) intraocular pressure below 21 mmHg; (4) no active epithelial defect or signs of acute rejection; and (5) suture integrity confirmed. For DMEK patients, if a rebubbling procedure (air re-injection for graft detachment) is required in the first 1–2 weeks, the fit-to-fly timeline resets by approximately 7–10 days. Cabin pressure at typical commercial flight altitudes (equivalent to 6,000–8,000 ft) does not adversely affect a properly healed corneal graft, but the low humidity of aircraft cabins necessitates intensive preservative-free lubricating eye drops during the flight. Your surgeon will issue a formal fit-to-fly letter, and GAF Healthcare will coordinate with your home-country ophthalmologist to ensure continuity of care immediately upon your return.

Q: What is the success rate of cornea transplant surgery?

Cornea transplantation has one of the highest success rates of any tissue transplant. For primary DMEK (the preferred technique for Fuchs dystrophy and endothelial failure), published registry data and high-volume centre series report graft survival exceeding 90–95% at 5 years and 80–85% at 10 years, with more than 50% of patients achieving a best-corrected visual acuity of 20/20 or better by 3 months. Endothelial rejection — the principal long-term threat to graft survival — occurs in fewer than 1–2% of DMEK recipients compared to 10–15% after full-thickness penetrating keratoplasty. For DALK (used in keratoconus), graft survival approaches 95–98% at 5 years because the patient's own endothelium is preserved and endothelial rejection is virtually eliminated. Success rates are lower in high-risk eyes: repeat grafts (failed prior transplant) carry a 5-year survival of approximately 70–80%, and eyes with uncontrolled glaucoma, limbal stem cell deficiency, or prior chemical burns have further reduced prognoses. The surgeons at GAF Healthcare's partner centres — operating at institutions that perform hundreds of keratoplasties annually — consistently achieve outcomes in line with or exceeding international benchmarks reported by the Cornea Donor Study and European Eye Bank Association data.

Cornea Transplant in India

Get Cornea Transplant at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.

Cornea Transplant in UAE

Cornea Transplant at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.

Overview

Cornea transplantation — encompassing full-thickness penetrating keratoplasty (PK) and the newer lamellar techniques such as DSAEK and DMEK — restores vision lost to corneal scarring, ectasia, or endothelial failure, with graft survival rates exceeding 90% at five years for primary procedures. International patients increasingly choose India and the UAE for this procedure, benefiting from world-class ophthalmic microsurgeons, tissue-matched donor corneas processed to EBAA standards, and costs that are a fraction of those in North America or Western Europe. GAF Healthcare coordinates every step of the journey — from donor cornea sourcing and surgeon selection at NABH- or JCI-accredited hospitals in India to premium JCI- and DHA-licensed eye centres in Dubai and Abu Dhabi — giving patients a seamless, medically supervised experience from first inquiry to final follow-up.

Hospital Stay: 1–2 days (day-surgery or overnight admission; longer for complex repeat grafts) • Total Stay in Country (Fit-to-Fly): 3–6 weeks (visual acuity and intraocular pressure must be stable; long-haul flight cabin pressure is safe once the anterior chamber is fully reformed and sutures are secure) • Success Rate: 90–95% graft survival at 5 years (primary DMEK/DSAEK); 80–85% for repeat grafts or high-risk corneas

What Is It?

The cornea is the eye's outermost transparent dome, responsible for roughly two-thirds of the eye's total refractive power and the primary barrier against infection and trauma. When its structural integrity is compromised — whether by Fuchs endothelial dystrophy, keratoconus, pseudophakic bullous keratopathy, herpetic stromal scarring, or chemical injury — light scattering and irregular astigmatism produce progressive, often irreversible visual impairment that spectacles and contact lenses can no longer correct. At the cellular level, the critical determinant of corneal clarity is endothelial cell density: a healthy cornea maintains approximately 2,000–3,000 cells/mm², and once this falls below ~500 cells/mm² the stroma becomes oedematous and opaque, a process called corneal decompensation.

The standard of care has shifted decisively over the past two decades away from full-thickness penetrating keratoplasty (PK) toward selective lamellar procedures that replace only the diseased tissue layer. Descemet Membrane Endothelial Keratoplasty (DMEK) replaces only the 10–15 µm Descemet membrane and its endothelium, leaving the patient's stroma and epithelium intact; it delivers faster visual rehabilitation (often 20/25 or better by 3 months), a lower rejection rate (~1% vs 10–15% for PK), and a structurally stronger eye. Deep Anterior Lamellar Keratoplasty (DALK) is preferred when the endothelium is healthy but the stroma and Bowman layer are scarred, as in advanced keratoconus; by retaining the host endothelium, DALK virtually eliminates endothelial rejection.

In India, high-volume cornea centres — particularly in Chennai, Hyderabad, Bengaluru, and Mumbai — perform thousands of keratoplasties annually, and their surgeons have contributed original research to the global DMEK literature. In the UAE, specialised eye hospitals in Dubai Healthcare City and Abu Dhabi's Cleveland Clinic and Moorfields Eye Hospital satellite campuses offer the same lamellar techniques within a luxury-medicine infrastructure, with rapid donor cornea import clearance through the Dubai Health Authority tissue-banking framework. Both ecosystems meet international accreditation standards and offer eye banks compliant with the Eye Bank Association of America (EBAA) or equivalent European tissue-banking directives.

Candidates

• ELIGIBLE CONDITIONS:

• Fuchs endothelial corneal dystrophy (Stage 3–4 with BCVA ≤ 20/50 or disabling glare/halos)

• Keratoconus with contact-lens intolerance or BCVA ≤ 20/40 (DALK preferred if endothelium intact; max K > 55D; Amsler–Krumeich Grade III–IV)

• Pseudophakic or aphakic bullous keratopathy (post-cataract corneal decompensation)

• Corneal scarring from herpes simplex/zoster stromal keratitis (quiescent ≥ 12 months)

• Post-infectious opacities (bacterial, acanthamoeba — fully treated and culture-negative)

• Lattice, granular, or macular stromal dystrophies

• Chemical or thermal burns with stromal opacification (after full ocular surface rehabilitation)

• Failed prior corneal graft (repeat PK or conversion to lamellar)

• REQUIRED PRE-OPERATIVE WORKUP:

• Slit-lamp biomicroscopy with photographic documentation

• Specular microscopy (endothelial cell density and morphology; ECD < 1,000 cells/mm² diagnostic of decompensation)

• Corneal topography and tomography (Pentacam/Scheimpflug — maps curvature, pachymetry, posterior elevation; mandatory for keratoconus staging)

• Anterior-segment OCT (AS-OCT: defines depth and extent of stromal pathology; guides DALK vs DMEK selection)

• Biometry and IOL power calculation if combined cataract surgery (triple procedure) is planned

• Intraocular pressure by Goldmann applanation (glaucoma exclusion; uncontrolled IOP is a relative contraindication)

• Dilated fundus examination and macular OCT (to rule out amblyopia or macular pathology limiting visual prognosis)

• Systemic workup: CBC, random blood glucose, HbA1c, HBsAg, Anti-HCV, HIV serology, ECG (for general anaesthesia candidates)

• CONTRAINDICATIONS & HIGH-RISK FLAGS:

• Active ocular surface inflammation or dry eye disease (Schirmer < 5 mm — must be optimised first)

• Uncontrolled glaucoma (IOP > 21 mmHg on maximum tolerated therapy)

• Severe ocular cicatricial pemphigoid or Steven–Johnson syndrome (limbal stem cell deficiency requires sequential LSCT before keratoplasty)

• Active herpetic epithelial disease (must achieve ≥ 12 months disease-free on antiviral prophylaxis)

• Amblyopia with visual potential < 20/200 (relative contraindication — patient counselling essential)

• Systemic immunosuppression (increases rejection risk; requires perioperative protocol adjustment)

• Uncontrolled diabetes mellitus (HbA1c > 9% — defer until optimised)

• Age < 2 years (Peters anomaly cases require paediatric anaesthesia specialist centre)

Procedure

FULL-THICKNESS PENETRATING KERATOPLASTY (PK / PKP)

The historical gold standard: a trephine (typically 7.5–8.5 mm diameter) excises the full corneal thickness in both donor and host. An interrupted or combined running-and-interrupted suture pattern (10-0 nylon) secures the graft. PK is still preferred for total corneal opacification involving all layers, severe anterior segment distortion, or when the surgical team lacks DMEK infrastructure. Disadvantages include 12–24 months of visual rehabilitation, induced irregular astigmatism (often requiring hard contact lenses), and a 10–20% lifetime rejection rate.

DESCEMET STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK / DSEK)

A 5 mm scleral incision allows folded insertion of a 100–150 µm donor disc (endothelium + Descemet + thin posterior stroma). Air tamponade for 60 minutes adheres the lenticule. DSAEK is technically easier to teach than DMEK and is preferred when the anterior chamber is shallow (post-vitrectomy, glaucoma-tube eyes) or in cases of iris abnormality. Visual outcomes are slightly inferior to DMEK (average 20/30–20/40 vs 20/25).

DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)

Currently the preferred technique for Fuchs dystrophy and bullous keratopathy in high-volume cornea centres. Only the 10–15 µm Descemet membrane scroll (no stromal backing) is implanted via a small-incision injector system. Key intraoperative technologies include trypan blue staining to identify graft orientation, intraoperative OCT (iOCT) for real-time graft unfolding confirmation, and the 'no-touch' technique using a glass pipette. Graft detachment (the principal complication, ~5–10%) is managed with rebubbling — a minor office procedure. Rejection rates are markedly lower (<1–2% at 5 years) and visual acuity of 20/20 is achievable in > 50% of eyes.

DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)

Reserved for stromal pathology with an intact endothelium (keratoconus, stromal dystrophies, anterior scars). The surgeon removes 95–99% of the stroma while preserving the patient's own Descemet–endothelial complex. The Big-Bubble technique (Anwar & Teichmann) uses intrastromal air injection to pneumatically dissect a perfect pre-Descemet plane; an alternative is the viscodissection or hydrodelamination approach. DALK eliminates endothelial rejection entirely and carries superior long-term graft survival (the patient's own endothelium is never at risk). Recovery mirrors PK (12–18 months for suture removal and stable refraction), but the structural globe integrity is superior.

ULTRA-THIN DSAEK (UT-DSAEK) AND DMEK-S (DMEK WITH STROMAL RIM)

Proprietary variations that aim to bridge the technical simplicity of DSAEK with the visual outcomes of DMEK. Donor tissue is microkeratome-cut to 50–70 µm (UT-DSAEK), improving best-corrected acuity to 20/25 in many series. DMEK-S retains a thin stromal rim for easier manipulation in complex anterior chambers.

SEQUENTIAL / COMBINED PROCEDURES

• Triple Procedure: simultaneous PK + cataract extraction + IOL implantation (reduces anaesthetic events; requires precise pre-operative biometry)

• DMEK + Phacoemulsification: increasingly performed in Fuchs patients with concurrent cataract; iOCT guidance recommended

• Limbal Stem Cell Transplantation (LSCT) → keratoplasty: mandatory staged approach in ocular surface failure

FEMTOSECOND LASER-ASSISTED KERATOPLASTY (FLAK)

Available at select premium centres in both India and the UAE. A femtosecond laser (IntraLase or VisuMax) creates precisely bevelled trephination profiles (zigzag, mushroom, top-hat) that increase wound surface area, improve self-sealing, and may reduce postoperative astigmatism compared with manual trephination in PK cases.

Cost of Cornea Transplant: India vs. UAE

Cornea transplantation costs vary substantially by destination, technique, and hospital tier. India offers the most cost-effective access to internationally trained corneal surgeons — with DMEK available at NABH- and JCI-accredited hospitals for a fraction of Western prices. The UAE delivers equivalent or superior infrastructure in a luxury clinical environment, with faster donor tissue access via international import channels. Both destinations include donor cornea procurement, surgical fees, theatre charges, one night of hospitalisation, and standard postoperative medications in the base package. Costs below are estimates in USD for a primary, single-eye procedure; bilateral or high-risk repeat grafts will be higher. GAF Healthcare provides a personalised cost estimate within 48 hours of receiving your ophthalmic records.

Destination	Estimated Cost (USD)	Key Advantage
India	$1,500 – $4,000	~58% less than the UAE
UAE (Dubai/Abu Dhabi)	$4,000 – $9,000	Premium care, JCI/DHA accredited

Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.

Recovery & Aftercare

PHASE 1 — PRE-TRAVEL EVALUATION (4–8 weeks before departure)

• GAF Healthcare coordinates secure upload of existing ophthalmic records (slit-lamp photos, Pentacam maps, specular microscopy reports) to the selected surgeon for remote triage.

• Surgeon issues a written operative plan specifying technique (DMEK / DALK / PK), anaesthesia type (topical + sedation vs general), and estimated donor cornea wait time (typically 1–4 weeks in India; 1–3 weeks in UAE via imported tissue).

• Patient obtains e-Medical Visa (India) or UAE entry visa; GAF prepares invitation letters and medical documentation.

• Systemic optimisation: blood glucose control, discontinuation of anticoagulants per surgeon's protocol, lubricating eye drops commenced if dry-eye is present.

PHASE 2 — ARRIVAL & FINAL ASSESSMENT (Days 1–3)

• Airport transfer by GAF-assigned coordinator; check-in at partner accommodation (serviced apartment or hospital guest house).

• Day 1: Dedicated pre-operative ophthalmology consultation — slit-lamp, AS-OCT, specular microscopy, biometry (if triple procedure), IOP, dilated fundus exam.

• Day 2: Anaesthesia fitness assessment; pre-operative blood tests; informed consent in patient's language (GAF provides certified medical interpreter).

• Day 3 (or as scheduled): Admission to hospital; nil-by-mouth from midnight if GA planned; topical antibiotic drops commenced.

PHASE 3 — SURGICAL DAY

• Procedure duration: DMEK 45–75 minutes; DALK 90–120 minutes; PK 60–90 minutes.

• Anaesthesia: Most lamellar procedures performed under monitored anaesthesia care (MAC) with sub-Tenon or topical block; PK often under general anaesthesia in anxious patients or complex cases.

• Intraoperative iOCT (where available) confirms graft position and unfolding in real time.

• For DMEK: 30–60 minutes supine positioning maintained post-operatively for air tamponade.

• Discharge: same day (day-surgery) or next morning after IOP check and slit-lamp confirmation of graft adherence.

PHASE 4 — EARLY POSTOPERATIVE PERIOD (Week 1–3, In-Country)

• Day 1 post-op: First slit-lamp review; check for primary graft adherence (DMEK) or wound integrity (PK/DALK); IOP measurement.

• Medications: Prednisolone acetate 1% hourly for 1 week then tapering over 6–12 months; topical antibiotic (moxifloxacin) for 4 weeks; cyclosporine 0.1% if high rejection risk; systemic oral prednisolone for high-risk cases.

• DMEK rebubbling (if graft detachment > 30%): minor procedure at slit-lamp or theatre; typically within Days 3–14.

• Week 2: Visual acuity check — DMEK patients often see 20/40 or better by Day 14; PK patients may see only light/hand movements due to sutures.

• Week 3: Slit-lamp, IOP, anterior-segment OCT; if graft is adherent and IOP is controlled, GAF's medical team clears patient for travel.

PHASE 5 — FIT-TO-FLY CLEARANCE (Weeks 3–6)

• Criteria for flight clearance: Formed anterior chamber, no epithelial defect, IOP < 21 mmHg, sutures intact, no signs of acute rejection.

• Surgeon issues a fit-to-fly letter; GAF provides emergency contact card with local ophthalmologist details for home country follow-up.

• Patient advised to carry all eye medications in carry-on luggage and wear protective eyewear during travel.

PHASE 6 — LONG-TERM RECOVERY AT HOME (Months 1–18)

• DMEK: Best corrected acuity often 20/20–20/25 by 3 months; topical steroid taper to once daily by Month 6.

• PK / DALK: Sutures remain in situ 12–18 months; refraction assessed only after selective suture removal; rigid gas-permeable or scleral lenses may be needed.

• Rejection surveillance: Patients educated on the classic 4 Rs — Redness, Reduced vision, Pain, Photophobia — and instructed to present to an ophthalmologist within 24 hours if any occur.

• Graft rejection (if caught early) is reversible in > 90% of cases with intensive topical and systemic steroids.

• Long-term follow-up reports are transmitted to GAF Healthcare, which relays findings to the operating surgeon for teleconsultation.

Risks & Considerations

Cornea transplantation is among the most successful tissue transplants in medicine, but patients must be counselled on a defined risk profile. The most feared early complication of DMEK is primary graft failure (< 2%), in which donor endothelial cells fail to function despite correct positioning — requiring re-grafting. Graft detachment occurs in 5–15% of DMEK cases and is managed by rebubbling (air re-injection), a straightforward in-office procedure that restores attachment in > 90% of cases without compromising final visual outcome. Acute graft rejection — mediated by host T-cell recognition of donor HLA antigens — presents with the classic '4 Rs' (Redness, Reduced vision, Pain, Photophobia) and occurs in 1–2% of DMEK recipients vs 10–15% after PK. Crucially, rejection diagnosed within 24 hours and treated with intensive topical prednisolone (hourly) and systemic steroids is reversible in the great majority of cases; delayed presentation leads to irreversible endothelial loss. Elevated intraocular pressure (steroid-response glaucoma) occurs in 10–15% of patients on prolonged topical prednisolone and must be monitored monthly; IOP-lowering drops or laser trabeculoplasty may be required. Suture-related complications in PK (suture abscess, vascularisation, high astigmatism) are managed by selective suture removal under slit-lamp control, typically after Month 12. Cataract formation accelerates after PK due to prolonged steroid use and is addressed with phacoemulsification once the graft is stable. Endophthalmitis (intraocular infection) is rare (< 0.1%) but vision-threatening; patients are instructed to seek emergency ophthalmic care for any sudden pain or vision loss. International patients must have a named ophthalmologist in their home country before travelling, as rejection episodes or IOP spikes can occur months to years postoperatively.

Top Hospitals for Cornea Transplant

The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.

🇮🇳

All India Institute of Medical Sciences (AIIMS)

New Delhi, India

NABH

🇮🇳

Christian Medical College (CMC)

Vellore, India

NABH ISO

🇮🇳

Manipal Hospitals Dwarka

New Delhi, India

NABH NABL

Top Doctors for Cornea Transplant

Internationally trained specialists in Ophthalmology. Review their profiles, compare experience, and connect directly through GAF Healthcare.

Dr. Jeewan Singh Titiyal

MBBS, MD (Ophthalmology), FRCOphth (Fellowship), DSc (Honorary Doctor of Science)

Ophthalmologist (Cornea, Cataract & Refractive Surgery)

Dr. Agarwal's Eye Hospital, New Delhi, India

37+ Yearsof experience

Dr. Jeewan Singh Titiyal is one of India's most respected eye surgeons, with a career spanning more than 37 years in cornea, cataract, and refractive surgery. He is a recipient of the Padma Shri (2014), one of India's highest civilian honours, awarded in recognition of his exceptional contributions to ophthalmology. Today he serves as Regional Head of Clinical Services at Dr. Agarwal's Eye Hospital in New Delhi, continuing a lifetime of service to… Read more

Dr. Srilathaa Gunasekaran

MD (Ophthalmology), FAICO (Cornea), FAICO (Refractive Surgery), Cornea Observership

Ophthalmologist — Cornea, Cataract & Refractive Surgery

Fortis Memorial Research Institute, Gurgaon, India

13+ Yearsof experience

Dr. Srilathaa Gunasekaran is a Senior Consultant Ophthalmologist at Fortis Memorial Research Institute, Gurgaon, with over 13 years of experience in cornea, cataract, and refractive surgery. She is one of the few ophthalmologists in the region who performs the full range of corneal transplant procedures — including full-thickness keratoplasty, lamellar surgeries, endothelial keratoplasty, and keratoprosthesis — making her a trusted choice for patients… Read more

Dr. Amrita Singh

MBBS, MS (Ophthalmology), Fellowship, Fellowship

Ophthalmologist & Cornea Specialist

The Sight Avenue Eye Hospital, New Delhi, India

17+ Yearsof experience

Dr. Amrita Singh is an experienced ophthalmologist based in the Delhi NCR region, with over 17 years dedicated to helping patients see the world more clearly. Her clinical focus spans cataract surgery, LASIK and refractive procedures, and complex corneal conditions — making her a trusted name for patients dealing with everything from routine vision correction to more intricate eye health challenges. Dr. Singh completed her MBBS and MS in Ophthalmology at… Read more

Dr. Rajesh Fogla

MBBS, MS (Ophthalmology), FRCS, FRCOphth, FACS, MMed

Ophthalmologist (Cornea, Cataract & Refractive Surgery)

Apollo Health City, Jubilee Hills, Hyderabad, India

25+ Yearsof experience

Dr. Rajesh Fogla is one of Hyderabad's most respected eye specialists, with over 25 years of dedicated practice in ophthalmology. Based at Apollo Health City in Jubilee Hills, he is particularly known for his expertise in cornea, cataract, and refractive surgery. Patients across India and from abroad seek him out for conditions ranging from routine vision correction to complex surgical challenges that require a steady, experienced hand. Dr. Fogla's… Read more

Dr. Garima Satija

MBBS, MS (Ophthalmology), Cornea Fellowship

Ophthalmologist – Cornea & Cataract Specialist

Fortis Memorial Research Institute, Gurgaon, India

8+ Yearsof experience

Dr. Garima Satija is an ophthalmologist at Fortis Memorial Research Institute, Gurgaon, with a focused practice in cornea, cataract, and anterior segment surgery. Over more than eight years in clinical practice, she has built a reputation for careful surgical technique and a genuinely patient-centered approach — taking the time to explain diagnoses and options in plain language before recommending any procedure. Her training path reflects a deliberate… Read more

Frequently Asked Questions — Cornea Transplant

For a primary, single-eye cornea transplant (DMEK or DSAEK), patients can expect to pay approximately USD 1,500–4,000 at leading NABH- and JCI-accredited hospitals in India (Chennai, Hyderabad, Mumbai, Bengaluru) and USD 4,000–9,000 at JCI- and DHA-licensed eye centres in Dubai and Abu Dhabi. These estimates include surgeon fees, theatre charges, donor cornea procurement and processing, one night of hospitalisation, and standard postoperative medications. India represents a saving of roughly 50–60% compared to the UAE for equivalent clinical quality — both destinations deploy DMEK, DALK, and femtosecond laser-assisted techniques by fellowship-trained corneal specialists. High-risk cases (repeat grafts, combined triple procedures, bilateral surgery) attract higher fees in both destinations. GAF Healthcare provides a personalised, itemised cost estimate within 48 hours of receiving your ophthalmic records and surgeon assessment.

The minimum in-country stay before international flight clearance is typically 3 weeks for uncomplicated DMEK or DALK, and up to 4–6 weeks for penetrating keratoplasty (PK) or complex cases. The key clinical milestones that must be met before flying are: (1) a fully formed, pressure-stable anterior chamber; (2) complete graft adherence confirmed on slit-lamp and/or anterior-segment OCT; (3) intraocular pressure below 21 mmHg; (4) no active epithelial defect or signs of acute rejection; and (5) suture integrity confirmed. For DMEK patients, if a rebubbling procedure (air re-injection for graft detachment) is required in the first 1–2 weeks, the fit-to-fly timeline resets by approximately 7–10 days. Cabin pressure at typical commercial flight altitudes (equivalent to 6,000–8,000 ft) does not adversely affect a properly healed corneal graft, but the low humidity of aircraft cabins necessitates intensive preservative-free lubricating eye drops during the flight. Your surgeon will issue a formal fit-to-fly letter, and GAF Healthcare will coordinate with your home-country ophthalmologist to ensure continuity of care immediately upon your return.

Cornea transplantation has one of the highest success rates of any tissue transplant. For primary DMEK (the preferred technique for Fuchs dystrophy and endothelial failure), published registry data and high-volume centre series report graft survival exceeding 90–95% at 5 years and 80–85% at 10 years, with more than 50% of patients achieving a best-corrected visual acuity of 20/20 or better by 3 months. Endothelial rejection — the principal long-term threat to graft survival — occurs in fewer than 1–2% of DMEK recipients compared to 10–15% after full-thickness penetrating keratoplasty. For DALK (used in keratoconus), graft survival approaches 95–98% at 5 years because the patient's own endothelium is preserved and endothelial rejection is virtually eliminated. Success rates are lower in high-risk eyes: repeat grafts (failed prior transplant) carry a 5-year survival of approximately 70–80%, and eyes with uncontrolled glaucoma, limbal stem cell deficiency, or prior chemical burns have further reduced prognoses. The surgeons at GAF Healthcare's partner centres — operating at institutions that perform hundreds of keratoplasties annually — consistently achieve outcomes in line with or exceeding international benchmarks reported by the Cornea Donor Study and European Eye Bank Association data.

Why Plan Your Treatment Through Gaf Healthcare?

GAF Healthcare provides a fully managed non-medical support infrastructure that removes the practical barriers to international corneal transplant care.

INDIA VISA & ENTRY GAF's visa team prepares and submits the e-Medical Visa (e-MV) application on the patient's behalf, including the mandatory hospital invitation letter on letterhead from the treating institution. The e-MV is typically granted within 3–5 business days, permits two companion attendants on an e-Medical Attendant Visa, and allows a stay of up to 60 days (extendable). GAF monitors application status and liaises with the Indian embassy or VFS centre in the patient's country.

UAE VISA & ENTRY Patients from GCC countries and most Western nations enter the UAE visa-free or receive a visa on arrival. For nationalities requiring advance clearance, GAF coordinates a medical visa through the Dubai Health Authority (DHA) or Department of Health Abu Dhabi (DoH), supported by the treating hospital's treatment plan and GAF's liaison letter. Visa processing typically takes 5–7 business days.

AIRPORT-TO-HOSPITAL TRANSFERS Dedicated, wheelchair-accessible vehicles with a GAF coordinator meet every patient on arrival. All inter-facility transfers (hotel to hospital, hospital to diagnostic centre, discharge to accommodation) are pre-scheduled and included in the package.

MEDICAL INTERPRETATION GAF maintains a network of certified medical interpreters for Arabic, Russian, French, Swahili, Bengali, and other languages. An interpreter attends all surgical consultations, consent discussions, and discharge briefings to ensure zero miscommunication on medication schedules or emergency contact procedures.

ACCOMMODATION FOR PATIENT & ATTENDANT GAF partners with serviced apartments and hotel blocks adjacent to partner hospitals, providing discounted rates and housekeeping services. For the postoperative period — during which the patient must maintain a supine or near-supine position for 24–48 hours after DMEK — accommodation is reviewed for suitability (adjustable beds, blackout curtains, proximity to the eye centre for rebubbling if needed).

TELECONSULTATION & FOLLOW-UP COORDINATION After return home, GAF's case managers schedule video teleconsultations between the patient's home ophthalmologist and the operating surgeon at 1 month and 3 months post-operatively, transmitting imaging and clinical notes securely via the GAF patient portal. Emergency contact lines are available 24/7.

Patients Also Explore

Other treatments commonly sought by patients considering Cornea Transplant.

Rhinoplasty (Nose Job)

Cosmetic Surgery

Liposuction

Cosmetic Surgery

Cochlear Implant

ENT

Hyperthyroidism Treatment

ENT